AzTrials
AzTrials

Subacute StrokeROOMMATENCT06728020

AggRegated System Of sensOrs and Multimedia Monitors: Technology for innovAtion and personalizaTion of rEhabilitation Care. (ROOMMATE)

A study testing Active Comparator: Conventional rehabilitation (Group A), ROOMMATE 1st and ROOMMATE 2nd in people with Subacute Stroke and Stroke; Subacute, run by Francesca Cecchi at 1 site in Italy.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this clinical trial is to assess whether the ROOMMATE system can effectively support the rehabilitation of adults recovering from subacute strokes. The study will be conducted at the neuromotor rehabilitation inpatient clinics of IRCCS Fondazione Don Carlo Gnocchi in Florence, Italy, and the rehabilitation… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Subacute Stroke, Stroke; Subacute
What is being tested?
Active Comparator: Conventional rehabilitation (Group A), ROOMMATE 1st and ROOMMATE 2nd
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteItaly
Study dates
Apr 2025to May 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • outcome of ischemic or hemorrhagic stroke in subacute phase (< 3 months after the event)
  • willingness to participate in the project, with informed consent signed by the subject or, when necessary, by the support administrator.

Who cannot join

  • severe visual and/or auditory impairments that cannot be corrected
  • severe cognitive and/or speech impairments that interfere with the ability to use the HKK system and the SensoMode accessory independently and/or in the
  • absence of a caregiver who can assist the patient in using the system;
  • skin lesions that prevent wearing the inertial sensors;
  • presence of signs of clinical instability, defined by a score greater than zero on the Clinical Instability Scale (SIC).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Francesca Cecchi contact

+39 3388627184

fcecchi@dongnocchi.it

Italy1 site
  • IRCCS Fondazione Don Carlo Gnocchi Onlus

    Florence, Florence

    Francesca Cecchi, Associate Professor, +39 3388627184, fcecchi@dongnocchi.it

    Stefano Doronzio, PT, Phds, +39 3924685537, sdoronzio@dongnocchi.it

Other trials in Italy

About this study

Official title: ROOMMATE - AggRegated System Of sensOrs and Multimedia Monitors: Technology for innovAtion and personalizaTion of rEhabilitation Care.

The aim of this clinical trial is to assess whether the ROOMMATE system can effectively support the rehabilitation of adults recovering from subacute strokes. The study will be conducted at the neuromotor rehabilitation inpatient clinics of IRCCS Fondazione Don Carlo Gnocchi in Florence, Italy, and the rehabilitation inpatient unit of Elias University Emergency Hospital in Bucharest, Romania.

Primary Objectives:

Read more

-To assess the effects on functional recovery in subacute stroke survivors of a technological rehabilitation station placed at patients' bedsides, combined with dedicated coaching provided to all users (patients, informal caregivers, and formal caregivers).

Secondary Objectives:

  • Evaluation of the effects of the experimental treatment on patient satisfaction, upper limb motor skills, manual dexterity, global cognitive functioning, anxiety, and depression.
  • Assessment of user experience, acceptance, and usability of the technology by patients and caregivers.
  • Evaluation of social impact using the Social Return on Investment (SROI) ratio of the experimental treatment.

Participants randomized into one of the experimental groups, in addition to receiving conventional care, will use the ROOMMATE system during their hospitalization. The system will be made available to patients and will be free for them to use at their discretion.

The station will include:

Multimedia monitors (Khymeia home kit): These will deliver cognitive and motor serious games, educational and rehabilitative content, as well as infotainment specifically developed by the clinical partners of the project.

An inertial sensor kit: This integrates with the monitors to guide users through virtual reality environments.

Read the detailed description

Study Procedures

The study involves three successive phases:

Phase 1 During the first phase, after obtaining Ethics Committee approval, Living Labs will be planned. In these sessions, end users will test the proposed solutions and provide feedback on acceptability and usability. This phase is critical for defining user and system requirements. Additionally, health professionals will be trained as system coaches to support patients and their families in the subsequent phases.

The coaches will be selected from health professionals (physical therapists, occupational therapists, speech therapists, psychologists, nurses) with at least three professionals per center. They will complete a one-week course in digital literacy (e-literacy), covering:

  • Technical and operational skills for managing and using digital technologies.
  • Information and navigation skills.
  • Specific training on the use of the Khymeia Home Kit.
  • Training on using the inertial sensors developed by UNIFI. The training will conclude with a written and practical exam.

Subsequently, a multicenter multiple cohort RCT (cmRCT) will be conducted, consisting of two trials:

  1. A first RCT (Phase 2 of the study).
  2. A second pilot RCT (Phase 3 of the study). The study will be carried out in an inpatient setting for individuals with subacute stroke outcomes at the two clinical centers: IRCCS Fondazione Don Carlo Gnocchi in Florence, Italy, and Elias University Emergency Hospital in Bucharest, Romania.

The cmRCT design was chosen to address some limitations of traditional RCTs, such as issues with recruitment, ethics, patient preferences, and treatment comparison. Moreover, the cmRCT allows the simultaneous evaluation of different interventions.

In ROOMMATE, eligible patients who consent to baseline (T0) and final (T1, three weeks later) assessments may also be offered an additional intervention, forming the ROOMMATE Study Cohort. A subset of these patients will be randomized to receive an offer to participate in the ROOMMATE Interventions (B or B1), while those not randomized will form the control group (A, receiving usual care). This design will allow two successive RCTs to be conducted.

Phase 2

The first RCT will compare usual care (A) with a preliminary version of the ROOMMATE solution (B), which includes:

  • Usual care.
  • The Khymeia Home Kit monitor.
  • Educational and rehabilitative content developed by clinical partners.
  • Coaching for technology use. The sample size for this RCT is 140 patients, randomly assigned to Group A or B, with competitive enrollment across the two clinical centers.

The Khymeia Home Kit, supplemented with educational content, can be used by patients alone or with a caregiver. The educational materials will include:

  • General information about stroke pathogenesis and prognosis.
  • Strategies and advice for managing the condition.
  • Health-related content, such as details on daily hospitalization routines, the roles of various care professionals, and discharge management (including bureaucratic aspects).
  • Information on local support networks. Additional cognitive and motor rehabilitation content will be developed by a multidisciplinary team and customized by department therapists to match each patient's needs and recovery potential.

The coach will be available in person five days a week to support all end users in using the ROOMMATE technology.

Phase 3

Following the completion of the first RCT, a second pilot RCT with 60 patients will test usual care (A) against a mature version of the ROOMMATE solution (B1). This includes:

  • Usual care.
  • Motor and cognitive treatment supported by inertial sensor assessment for personalized interventions.
  • Integration of clinical assessments with IMU-derived reports.
  • Educational and rehabilitative content developed by clinical partners.
  • Coaching for technology use. In Group B1, the Khymeia Home Kit (with educational and rehabilitation content) will be enhanced with inertial sensors developed by UNIFI. These sensors will measure hand motility and provide tailored rehabilitation interventions.

The ROOMMATE intervention will last three weeks per patient. During this period:

  • Group B patients will receive training in using the technology from the coach.
  • Patients and their families will have self-directed or supervised access to HKK features, including educational, rehabilitative, and infotainment content.
  • Therapists will recommend the most appropriate content based on the patient's needs.
  • In Group B1, the physician will use inertial sensor data to quantify motor deficits and tailor the treatment accordingly.

Assessments (T0 and T1)

At baseline (T0) and post-treatment (T1), the following will be assessed:

  • Demographics: Sex, age, education.
  • Clinical data: Type of stroke, time since stroke, lesion laterality.
  • Primary and secondary outcomes: Disability in ADLs (modified Barthel Index, mBI). Manual dexterity. Upper limb motor skills. Neuropsychological and global cognitive functioning. Anxiety and depression. Quality of life.

At post-treatment (T1), also the following will be assessed:

  • Primary and secondary outcomes: Usability, feasibility, and social impact measures. User experience and education evaluation. Wearability of sensors. Social impact and patient satisfaction.
Being tested
Active Comparator: Conventional rehabilitation (Group A), ROOMMATE 1st, ROOMMATE 2nd
Keywords
subacute stroke, Neurorehabilitation, Assistive/rehabilitation robotics, Digital health, Continuum of care, People-centered care, Accessible care, Innovation adoption, cmRCT, Enriched environment
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active Comparator: Conventional rehabilitation (Group A)Other

    The conventional group will undergo standard rehabilitation treatment according to the rehabilitation plan developed by the rehabilitation team. This group will undergo 3 hours of rehabilitation per day and will carry out face-to-face rehabilitation following an impairment-based approach aimed at the treatment of motor-cognitive functions.

  • ROOMMATE 1stDevice

    In addition to Group A, this group will have the bedside multimedia monitor apparatus to access informative, rehabilitation, and entertainment content. Additionally, this group will have a digital and innovation coach to receive support in using the technology.

  • ROOMMATE 2ndDevice

    Once the first RCT of the cmRCT is completed, a pilot RCT will be initiated, randomizing 60 cases between Group A and this group. In addition to conventional treatment, this group will have a version of the ROOMMATE system integrated with inertial sensors worn on the hands and fingers to guide the serious games on the platform.

Study groups in NCT06728020
Study groupRoleWhat they receive
Conventional rehabilitation (Group A)Active comparatorThe first 140 patients who meet the inclusion criteria will be randomized between this group and group B. This group will undergo conventional therapy.
Receives: Other: Active Comparator: Conventional rehabilitation (Group A)
ROOMMATE 1st (Group B)ExperimentalThe 70 patients randomized to this group will undergo conventional treatment and, in addition, will have the first version of the ROOMMATE system.
Receives: Device: ROOMMATE 1st
ROOMMATE 2nd (Goup B2)ExperimentalGroup B2 will undergo conventional treatment and will have an extended version of the bedside multimedia monitor apparatus, integrated with an inertial sensor to enable the serious games on the experimental platform.
Receives: Device: ROOMMATE 2nd

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. modified Barthel index (mBI)

    Assessment of disability in ADLs, scoring 0-100

    Measured: baseline, 3 week

Secondary outcomes (12)
  1. Nine Hole Peg Test

    Manual Dexterity, evaluated in seconds

    Measured: baseline, 3 week

  2. Fugl Meyer Assessment (FMA)

    Upper limb motor skills, scoring 0 - 126

    Measured: baseline, 3 week

  3. Functional Ambulation Category (FAC)

    functional ambulation assessment, scoring 0-5

    Measured: baseline, 3 week

  4. Montreal Cognitive Assessment (MOCA)

    Cognitive impairment assessment, scoring 0 - 30

    Measured: baseline, 3 week

  5. Hearts Test

    3-minute visual attention barrage test, scores 0-50

    Measured: baseline, 3 week

  6. Short Form 12 item

    generic assessment of quality of life, scoring 0-47

    Measured: baseline, 3 week

  7. Training-Evaluation-Inventory (TEI)

    evaluation of the course and its contents, a 45 item scale scoring with a 5 point likert scale

    Measured: 3 week

  8. Short Version of the User Experience Questionnaire (UEQ-S)

    user expirience assessment, 8 item scale scoring with a 7 point likert scale

    Measured: 3 week

  9. Final Measurement Scales for Perceived Usefulness and Perceived Ease of Use

    Acceptance Assessment of the ROOMATE sistem, a 12 item scale scoring with a 7 point likert scale

    Measured: 3 week

  10. HUBBI - eHealth UsaBility Benchmarking Instrument

    Usability Assessment of the ROOMATE sistem, a 18 item scale scoring with a 5 point likert scale

    Measured: 3 week

  11. we wearability test

    Sensors Wearability Assessment, likert scale, scores 1-5

    Measured: 3 week

  12. Motricity Index

    Upper limb and lower limb motor skills, scoring 0 - 100

    Measured: baseline, 3 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Dec 2024
  2. Study startApr 2025 (estimated)
  3. Primary completionMay 2026 (estimated)
  4. Study completionMay 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Three phases: in the first, focus groups and living labs are conducted to co-create the solution with patients; in the second, as the first action of the cmRCT, an RCT is conducted to verify the effectiveness of the initial ROOMMATE system; in the third, a pilot is conducted to preliminarily test the advanced version of the ROOMMATE system.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06728020
Sponsor's protocol ID
cmRCT ROOMMATE
Other IDs
Grant Agreement Nº: 101095654.
Acronym
ROOMMATE
Status last verified
Mar 2025
First submitted
27 Nov 2024
Last updated
21 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: After publishing the results in international congresses and conferences and in impacted journals, the project partners, according to the stipulated data management plan will disseminate the results following the principle of "as open as possible, as closed as needed". Resuls will be shared on a Zenodo-like repository.

Publications

  • Doronzio S, Jansen-Kosterink S, Tesi M, Castagnoli C, Pedrini C, Ciapetti T, De Marco M, Piazzini M, Giacani J, Ciobanu I, Berteanu M, Fiorini L, Rovini E, Cavallo F, Agnoloni F, Baccini M, Cecchi F. Development of a cohort multiple randomized clinical trial to test an integrated system of sensors and multimedia monitors technology, for stroke rehabilitation: the ROOMMATE study protocol. Front Neurol. 2025 Oct 14;16:1568728. doi: 10.3389/fneur.2025.1568728. eCollection 2025.

    PubMed 41164394

Questions about this trial

What is this clinical trial studying?

A study testing Active Comparator: Conventional rehabilitation (Group A), ROOMMATE 1st and ROOMMATE 2nd in people with Subacute Stroke and Stroke; Subacute, run by Francesca Cecchi at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 21 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Francesca Cecchi (+39 3388627184, fcecchi@dongnocchi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

modified Barthel index (mBI) (time frame: baseline, 3 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06728020, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in